Novel targeted therapeutic strategies in the treatment of triple-negative breast cancer

Research output: ThesisDoctoral Thesis

25 Downloads (Pure)

Abstract

Triple-negative breast cancers (TNBCs) remain one of the most challenging subtypes of breast cancer to be treated clinically. , Currently, no targeted therapies are available leaving chemotherapy the only option. Here, I describe a novel approach to inhibit highly overexpressed transcription factors (TFs) in TNBCs that drive high cell proliferation and poor survival in these tumours, by harnessing interference peptides to specifically block the binding of these TFs to their endogenous cofactors. The body of work outlined in this thesis demonstrates the power of novel targeted approaches to sensitise highly metastatic and resistant tumours to chemotherapy.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • The University of Western Australia
Award date15 Mar 2019
DOIs
Publication statusUnpublished - 2019

Fingerprint Dive into the research topics of 'Novel targeted therapeutic strategies in the treatment of triple-negative breast cancer'. Together they form a unique fingerprint.

  • Cite this